212
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Perceptions and Attitudes of Patients and Their Family Caregivers on Nebulization Therapy for COPD

, , , &
Pages 2277-2288 | Received 18 Apr 2022, Accepted 02 Aug 2022, Published online: 14 Sep 2022

References

  • World Health Organization. Chronic obstructive pulmonary disease (COPD). World Health Organization. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed 28 January, 2021.
  • Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–221. doi:10.1183/09059180.00003609
  • Soriano JB, Kendrick PJ, Paulson KR, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/s2213-2600(20)30105-3
  • Hossain MM, Sultana A, Purohit N. Burden of chronic obstructive pulmonary disease in India: status, practices and prevention. Int J Pulmonary Respir Sci. 2018;2. doi:10.19080/IJOPRS.2018.02.555599
  • Salvi S, Kumar GA, Dhaliwal RS, et al. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the global burden of disease study 1990–2016. Lancet Glob Health. 2018;6(12):e1363–e1374. doi:10.1016/s2214-109x(18)30409-1
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: https://goldcopd.org/uploads/users/. Accessed 28 January, 2021.
  • NHS. Treatment-chronic obstructive pulmonary disease (COPD). Available from: https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/. Accessed 28 January, 2021.
  • Broeders ME, Sanchis J, Levy ML, Crompton GK, Dekhuijzen PN. The admit series–issues in inhalation therapy. 2. Improving technique and clinical effectiveness. Prim Care Respir J. 2009;18(2):76–82. doi:10.4104/pcrj.2009.00025
  • Navaie M, Dembek C, Cho-Reyes S, Yeh K, Celli BR. Inhaler device feature preferences among patients with obstructive lung diseases: a systematic review and meta-analysis. Medicine. 2020;99(25):e20718. doi:10.1097/md.0000000000020718
  • van Haarst A, McGarvey L, Paglialunga S. Review of drug development guidance to treat chronic obstructive pulmonary disease: US and EU perspectives. Clin Pharmacol Ther. 2019;106(6):1222–1235. doi:10.1002/cpt.1540
  • Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® soft mist™ inhaler. Int J Chron Obstruct Pulmon Dis. 2009;4:381–390. doi:10.2147/COPD.S3391
  • Fromer L, Goodwin E, Walsh J. Customizing inhaled therapy to meet the needs of COPD patients. Postgrad Med. 2010;122(2):83–93. doi:10.3810/pgm.2010.03.2125
  • O’Conor R, Muellers K, Arvanitis M, et al. Effects of health literacy and cognitive abilities on COPD self-management behaviors: a prospective cohort study. Respir Med. 2019;160:105630. doi:10.1016/j.rmed.2019.02.006
  • Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American college of chest physicians/American college of asthma, allergy, and immunology. Chest. 2005;127(1):335–371. doi:10.1378/chest.127.1.335
  • Tashkin DP. A review of nebulized drug delivery in COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2585–2596. doi:10.2147/copd.S114034
  • Dhand R, Dolovich M, Chipps B, Myers TR, Restrepo R, Farrar JR. The role of nebulized therapy in the management of COPD: evidence and recommendations. Copd. 2012;9(1):58–72. doi:10.3109/15412555.2011.630047
  • Nakken N, Janssen DJ, van den Bogaart EH, et al. Informal caregivers of patients with COPD: home sweet home? Eur Respir Rev. 2015;24(137):498–504. doi:10.1183/16000617.00010114
  • Sharafkhaneh A, Wolf RA, Goodnight S, Hanania NA, Make BJ, Tashkin DP. Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. Copd. 2013;10(4):482–492. doi:10.3109/15412555.2013.773302
  • Anderson P. Patient preference for and satisfaction with inhaler devices. Eur Respir Rev. 2005;14(96):109–116. doi:10.1183/09059180.05.00009606
  • Market research society of india. Market research society of India. Availbale from: https://www.mrsi.co.in/. Accessed 28 January, 2021.
  • Rules & regulations of the market research society of india. Market research society of India. Available from: https://www.mrsi.co.in/pdf/Rules_Regulations.pdf. Accessed 23 June, 2022.
  • Ghoshal AG, Salvi S, Dhar R, et al. Consensus document on home nebulization for maintenance treatment of obstructive airway diseases: a joint initiative by the national allergy asthma bronchitis institute (naabi) and chest research foundation (crf). J Assoc Physicians India. 2017;65(5):60–73.
  • Barta SK, Crawford A, Roberts CM. Survey of patients’ views of domiciliary nebuliser treatment for chronic lung disease. Respir Med. 2002;96(6):375–381. doi:10.1053/rmed.2001.1292
  • Melani AS, Sestini P, Aiolfi S, et al. Genebu project: home nebulizer use and maintenance in Italy. Eur Respir J. 2001;18(5):758–763. doi:10.1183/09031936.01.00231701
  • Braman SS, Carlin BW, Hanania NA, et al. Results of a pulmonologist survey regarding knowledge and practices with inhalation devices for COPD. Respir Care. 2018;63(7):840–848. doi:10.4187/respcare.05717
  • Medicine CE. Expert consensus on nebulization therapy in pre-hospital and in-hospital emergency care. Ann Transl Med. 2019;7(18):487. doi:10.21037/atm.2019.09.44
  • Terry PD, Dhand R. Maintenance therapy with nebulizers in patients with stable COPD: need for reevaluation. Pulm Ther. 2020;6(2):177–192. doi:10.1007/s41030-020-00120-x